Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia

@far_cry0 you were asking about MIN-101 news. I think this is old news, but still interesting.


Looks like old news to me

1 Like

Yes you are correct. But maybe some people are just now hearing about this drug for the first time. There are many newcomers on the forum.


Thanks for sharing andrey …!!!